{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:53:00Z","timestamp":1793335980664,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["journals.elsevierhealth.com","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.eururo.2013.06.049","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T11:15:35Z","timestamp":1372936535000},"page":"350-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":298,"title":["Correlation of Pathologic Complete Response with Survival After Neoadjuvant Chemotherapy in Bladder Cancer Treated with Cystectomy: A Meta-analysis"],"prefix":"10.1016","volume":"65","author":[{"given":"Fausto","family":"Petrelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Coinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cabiddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Ghilardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivano","family":"Vavassori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Barni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2013.06.049_bib0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-5347(17)48996-8","article-title":"Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium","volume":"133","author":"Sternberg","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0010","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","article-title":"Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study","volume":"18","author":"von der Maase","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0015","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(03)13580-5","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2013.06.049_bib0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer [published correction appears in N Engl J Med 2003;349:1880]","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2013.06.049_bib0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/00365590902854313","article-title":"Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma","volume":"43","author":"Granfors","year":"2009","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0030","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.urology.2007.08.044","article-title":"Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection","volume":"70","author":"Nielsen","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2013.06.049_bib0035","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0022-5347(01)67614-6","article-title":"Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study","volume":"153","author":"Martinez-Pi\u00f1eiro","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0040","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/cncr.23848","article-title":"A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience","volume":"113","author":"Dash","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2013.06.049_bib0045","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/cncr.24466","article-title":"Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy","volume":"115","author":"Sonpavde","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2013.06.049_bib0050","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.eururo.2011.12.010","article-title":"Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer","volume":"61","author":"Rosenblatt","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ejso.2013.01.003","article-title":"Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experience","volume":"39","author":"Meijer","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0060","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/jjco\/hyr068","article-title":"Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer","volume":"41","author":"Kaneko","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0065","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1464-410X.2010.09574.x","article-title":"Induction chemotherapy for unresectable urothelial carcinoma of the bladder","volume":"107","author":"Ghadjar","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.06.049_bib0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10147-004-0474-5","article-title":"The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan","volume":"10","author":"Matsui","year":"2005","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0075","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1023\/A:1008350518083","article-title":"Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder","volume":"10","author":"Sternberg","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0080","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/030089169608200511","article-title":"Neoadjuvant CMV chemotherapy plus radical cystectomy in locally advanced bladder cancer: the impact of pathologic response on long-term results","volume":"82","author":"Scattoni","year":"1996","journal-title":"Tumori"},{"key":"10.1016\/j.eururo.2013.06.049_bib0085","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0022-5347(01)65852-X","article-title":"Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer","volume":"156","author":"Donat","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0090","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/0959-8049(96)00114-1","article-title":"Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancer","volume":"32A","author":"Sagaster","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2013.06.049_bib0095","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.1994.12.5.975","article-title":"Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer","volume":"12","author":"Herr","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000475285","article-title":"Neoadjuvant chemotherapy for invasive bladder carcinoma: disease outcome and bladder preservation and relationship to local tumor response","volume":"25","author":"Hatcher","year":"1994","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0105","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0022-5347(17)35630-6","article-title":"Neoadjuvant cisplatin, methotrexate and vinblastine for muscle-invasive bladder cancer: long-term followup","volume":"150","author":"Dreicer","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0110","doi-asserted-by":"crossref","first-page":"446","DOI":"10.6004\/jnccn.2013.0059","article-title":"Bladder cancer","volume":"11","author":"Clark","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.eururo.2013.06.049_bib0115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eururo.2012.08.010","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: chemotherapy for urothelial carcinoma\u2014neoadjuvant and adjuvant settings","volume":"63","author":"Sternberg","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0120","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.acuro.2011.11.001","article-title":"Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines [in Spanish]","volume":"36","author":"Stenzl","year":"2012","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.eururo.2013.06.049_bib0125","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00428-012-1249-4","article-title":"Retrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapy","volume":"461","author":"D'Souza","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/j.eururo.2013.06.049_bib0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.ju.0000162018.40891.ba","article-title":"Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer","volume":"174","author":"Nieuwenhuijzen","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.urology.2008.07.035","article-title":"Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy","volume":"73","author":"Kassouf","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2013.06.049_bib0140","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1016\/j.ejca.2012.05.023","article-title":"Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy","volume":"48","author":"Houssami","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2013.06.049_bib0145","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0150","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.juro.2012.10.120","article-title":"Pooled analysis of clinical outcomes with neoadjuvant cisplatin and gemcitabine chemotherapy for muscle invasive bladder cancer","volume":"189","author":"Yuh","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0155","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1200\/JCO.2011.38.6979","article-title":"Randomized phase III study comparing paclitaxel\/cisplatin\/gemcitabine and gemcitabine\/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987","volume":"30","author":"Bellmunt","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0160","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1200\/JCO.2010.34.4028","article-title":"Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status","volume":"29","author":"Stadler","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0165","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/cncr.24106","article-title":"Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series","volume":"115","author":"Weight","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2013.06.049_bib0170","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-5347(17)37318-4","article-title":"The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer\u2014Genitourinary Group","volume":"147","author":"Splinter","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.eururo.2012.10.008","article-title":"A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens","volume":"63","author":"Hansel","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.06.049_bib0180","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1002\/cncr.20282","article-title":"Pathologic evaluation of radical cystectomy specimens: a cooperative group report","volume":"100","author":"Herr","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2013.06.049_bib0185","first-page":"18","article-title":"Guidelines for data to be included in consultation reports on breast cancer, bladder cancer, and Hodgkin's disease","volume":"40","author":"College of American Pathologists","year":"1986","journal-title":"Pathologist"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283813006647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283813006647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T03:54:38Z","timestamp":1563335678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283813006647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0302283813006647"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2013.06.049","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of Pathologic Complete Response with Survival After Neoadjuvant Chemotherapy in Bladder Cancer Treated with Cystectomy: A Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2013.06.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}